Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Cyclacel Pharmaceuticals (CYCCP) Competitors

Cyclacel Pharmaceuticals logo

CYCCP vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CEROW

Should you be buying Cyclacel Pharmaceuticals stock or one of its competitors? The main competitors of Cyclacel Pharmaceuticals include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry.

Cyclacel Pharmaceuticals vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and Cyclacel Pharmaceuticals (NASDAQ:CYCCP) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation, profitability and media sentiment.

In the previous week, Cyclacel Pharmaceuticals had 2 more articles in the media than 180 Life Sciences. MarketBeat recorded 2 mentions for Cyclacel Pharmaceuticals and 0 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 0.00 equaled Cyclacel Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
Cyclacel Pharmaceuticals Neutral

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Cyclacel Pharmaceuticals N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Cyclacel PharmaceuticalsN/AN/AN/AN/AN/A

Summary

Cyclacel Pharmaceuticals beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get Cyclacel Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYCCP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CYCCP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CYCCP vs. The Competition

MetricCyclacel PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$127.96M$5.56B$9.05B
Dividend Yield0.12%3.74%5.24%3.99%
P/E RatioN/A3.4027.6520.23
Price / SalesN/A4,084.30419.56119.26
Price / CashN/A13.1926.2128.59
Price / BookN/A42.828.035.65
Net IncomeN/A-$92.79M$3.18B$249.15M

Cyclacel Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CYCCP
Cyclacel Pharmaceuticals
N/A$6.25
+17.9%
N/A-27.3%$0.00N/A0.0012
ATNFW
180 Life Sciences
N/A$0.01
+7.5%
N/A-6.9%$0.00N/A0.007Positive News
Gap Down
SXTPW
60 Degrees Pharmaceuticals
N/A$0.06
+11.5%
N/A-17.4%$0.00$665.45K0.002Gap Up
DRTSW
Alpha Tau Medical
N/A$0.25
+2.9%
N/A+5.5%$0.00N/A0.0080News Coverage
Positive News
WENAW
Anew Medical
N/A$0.04
-0.3%
N/AN/A$0.00N/A0.00N/AGap Down
APLMW
Apollomics
N/A$0.04
-19.2%
N/AN/A$0.00N/A0.0059Positive News
BCTXW
BriaCell Therapeutics
N/A$0.07
-2.4%
N/A-70.6%$0.00N/A0.008Gap Down
CDIOW
Cardio Diagnostics
N/A$0.02
+9.5%
N/A-59.5%$0.00$19.90K0.007Gap Down
CTCXW
Carmell
N/A$0.03
+6.8%
N/A-63.2%$0.00$32.84K0.0014Gap Up
CELUW
Celularity
N/A$0.05
+7.4%
N/A+100.0%$0.00$54.22M0.00220Positive News
Gap Down
CEROW
CERo Therapeutics
N/A$0.02
-13.9%
N/A+25.0%$0.00N/A0.008Positive News
Gap Down

Related Companies and Tools


This page (NASDAQ:CYCCP) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners